Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

From the authors:

S. Lahzami, J-D. Aubert
European Respiratory Journal 2010 36: 1495; DOI: 10.1183/09031936.00129810
S. Lahzami
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Samir.Lahzami@chuv.ch
J-D. Aubert
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

From the authors:

We thank E. Marchand for his interest and comments regarding our manuscript. We agree that our cohort of severe chronic obstructive pulmonary disease (COPD) patients undergoing lung transplantation 1 differed from the original BODE (body mass index, airflow obstruction, dyspnoea and exercise capacity) index validation cohort 2 by being of a younger age and by the absence of current smokers. This may have led, as suggested, to an underestimation of our cohort's predicted survival.

However, pulmonary hypertension 3, 4 and hypercapnia 5, 6 are other COPD prognostic factors that may have differentiated our cohort from the BODE index validation cohort. Indeed, as both are longstanding criteria for lung transplant listing in COPD patients 7, it is likely that patients with hypercapnia and pulmonary hypertension were over-represented in our cohort when compared to patients with similar BODE index scores in the BODE index validation cohort. In contrast to the differences in age and current smoking status, this may have led to an overestimation of our cohort's predicted survival.

As acknowledged in our article, the BODE index has not been specifically validated in a COPD population listed for transplantation. The 95% confidence interval of predicted survival was therefore used in our analysis. We believe that this allowed to account for most of the comorbidity differences between our cohort and the BODE index validation cohort.

The Lung Allocation Score (LAS), implemented in the USA since 2005, would theoretically be a more transplantation-specific predictor of survival. However, in contrast to the BODE index, it has not been prospectively validated. The survival probability while on waiting list and 1 yr after transplantation were both used to design the LAS. As such, it cannot be used to determine the effect of lung transplantation on survival. Furthermore, although an association with the probability of dying while on a waiting list has been demonstrated 8, the LAS has not been validated as a predictor of the duration of survival. The BODE index may not be the perfect tool to predict mortality in a COPD population listed for transplantation. Nevertheless, it is probably the best currently available one.

Footnotes

  • Statement of Interest

    A statement of interest for J-D. Aubert can be found at www.erj.ersjournals.com/site/misc/statements.xhtml

  • ©ERS 2010

REFERENCES

  1. ↵
    1. Lahzami S,
    2. Bridevaux PO,
    3. Soccal PM,
    4. et al
    . Survival impact of lung transplantation for COPD. Eur Respir J 2010; 36: 74–80.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Celli BR,
    2. Cote CG,
    3. Marin JM,
    4. et al
    . The body-mass-index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005–1012.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Incalzi RA,
    2. Fuso L,
    3. De Rosa M,
    4. et al
    . Electrocardiographic signs of chronic cor pulmonale: a negative prognostic finding in chronic obstructive pulmonary disease. Circulation 1999; 99: 1600–1605.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Oswald-Mammosser M,
    2. Weitzenblum E,
    3. Quoix E,
    4. et al
    . Prognostic factors in COPD patients receiving long-term oxygen therapy: importance of pulmonary artery pressure. Chest 1995; 107: 1193–1198.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Kanner RE,
    2. Renzetti AD Jr.,
    3. Stanish WM,
    4. et al
    . Predictors of survival in subjects with chronic airflow limitation. Am J Med 1983; 74: 249–255.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Foucher P,
    2. Baudoin N,
    3. Merati M,
    4. et al
    . Relative survival analysis of 252 patients with COPD receiving long-term oxygen therapy. Chest 1998; 113: 1580–1587.
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    International guidelines for the selection of lung transplant candidates. The American Society for Transplant Physicians (ASTP)/American Thoracic Society (ATS)/European Respiratory Society (ERS)/International Society for Heart and Lung Transplantation (ISHLT). Am J Respir Crit Care Med 1998; 158: 335–339.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Nunley DR,
    2. Bauldoff GS,
    3. Holloman CH,
    4. et al
    . The Lung Allocation Score and survival in lung transplant candidates with chronic obstructive pulmonary disease. Lung 2009; 187: 383–387.
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
View this article with LENS
Vol 36 Issue 6 Table of Contents
European Respiratory Journal: 36 (6)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
From the authors:
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
From the authors:
S. Lahzami, J-D. Aubert
European Respiratory Journal Dec 2010, 36 (6) 1495; DOI: 10.1183/09031936.00129810

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
From the authors:
S. Lahzami, J-D. Aubert
European Respiratory Journal Dec 2010, 36 (6) 1495; DOI: 10.1183/09031936.00129810
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • PDF

Subjects

  • COPD and smoking
  • Lung structure and function
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Latent COPD: a proposed new term in the disease nomenclature
  • Anti-anaerobic antibiotics: indication is key
  • Reply: Anti-anaerobic antibiotics: indication is key
Show more Correspondence

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society